Company’s 36-month beta value is 2.01.Analysts have differing opinions on the stock, with 1 analysts rating it as a “buy,” 0 as “overweight,” 4 as “hold,” and 1 as “sell.”
The public float for AVAH is 49.46M, and currently, short sellers hold a 3.24% ratio of that floaft. The average trading volume of AVAH on May 09, 2025 was 297.70K shares.
AVAH) stock’s latest price update
Aveanna Healthcare Holdings Inc (NASDAQ: AVAH)’s stock price has soared by 14.11 in relation to previous closing price of 4.82. Nevertheless, the company has seen a gain of 22.22% in its stock price over the last five trading days. zacks.com reported 2025-05-08 that While the top- and bottom-line numbers for Aveanna (AVAH) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
AVAH’s Market Performance
Aveanna Healthcare Holdings Inc (AVAH) has experienced a 22.22% rise in stock performance for the past week, with a 14.58% rise in the past month, and a 13.64% rise in the past quarter. The volatility ratio for the week is 6.87%, and the volatility levels for the past 30 days are at 5.86% for AVAH. The simple moving average for the past 20 days is 18.65% for AVAH’s stock, with a 11.87% simple moving average for the past 200 days.
Analysts’ Opinion of AVAH
UBS, on the other hand, stated in their research note that they expect to see AVAH reach a price target of $1.50. The rating they have provided for AVAH stocks is “Sell” according to the report published on November 30th, 2023.
AVAH Trading at 15.20% from the 50-Day Moving Average
After a stumble in the market that brought AVAH to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -11.15% of loss for the given period.
Volatility was left at 5.86%, however, over the last 30 days, the volatility rate increased by 6.87%, as shares surge +12.47% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +30.33% upper at present.
During the last 5 trading sessions, AVAH rose by +22.22%, which changed the moving average for the period of 200-days by +37.50% in comparison to the 20-day moving average, which settled at $4.64. In addition, Aveanna Healthcare Holdings Inc saw 20.35% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at AVAH starting from J.H. Whitney Equity Partners V, who sale 12,624 shares at the price of $5.63 back on Apr 02 ’25. After this action, J.H. Whitney Equity Partners V now owns 1,451,220 shares of Aveanna Healthcare Holdings Inc, valued at $71,073 using the latest closing price.
J.H. Whitney Equity Partners V, the 10% Owner of Aveanna Healthcare Holdings Inc, sale 5,580 shares at $5.63 during a trade that took place back on Apr 01 ’25, which means that J.H. Whitney Equity Partners V is holding 1,451,598 shares at $31,415 based on the most recent closing price.
Stock Fundamentals for AVAH
Current profitability levels for the company are sitting at:
- 0.07 for the present operating margin
- 0.31 for the gross margin
The net margin for Aveanna Healthcare Holdings Inc stands at -0.01. The total capital return value is set at 0.12.
Based on Aveanna Healthcare Holdings Inc (AVAH), the company’s capital structure generated 1.1 points at debt to capital in total, while cash flow to debt ratio is standing at 0.02. The debt to equity ratio resting at -10.92. The interest coverage ratio of the stock is 0.93.
Currently, EBITDA for the company is 192.84 million with net debt to EBITDA at 7.02. When we switch over and look at the enterprise to sales, we see a ratio of 1.15. The receivables turnover for the company is 7.29for trailing twelve months and the total asset turnover is 1.22. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.98.
Conclusion
In a nutshell, Aveanna Healthcare Holdings Inc (AVAH) has experienced a better performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
